PFGIA
PEARW

Patriot Financial Group Insurance Agency’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-166
Closed – – 2082
2022
Q2 		$0 Hold
166
– – ﹤0.01% 2219
2022
Q1 		$0 Hold
166
– – ﹤0.01% 2295
2021
Q4 		$0 Buy
+166
New +$169 ﹤0.01% 2296

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Patriot Financial Group Insurance Agency's PEARW Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q3 2022, closing a stake of 166 shares.

Patriot Financial Group Insurance Agency first reported a position in PEARW in Q4 2021 and held it in 3 quarters. The position peaked at $0 in Q2 2022. 36 funds tracked by Wall St. Rank hold PEARW as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Pear Therapeutics, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 166 Pear Therapeutics, Inc. Warrant shares in Q3 2022.
  • Patriot Financial Group Insurance Agency first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 3 quarters.
  • Patriot Financial Group Insurance Agency's Pear Therapeutics, Inc. Warrant position peaked at $0 in Q2 2022.
  • 36 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.